Elevance Health Inc. (NYSE: ELV) is identified as a cheap S&P 500 stock to invest in now. Mizuho and Wells Fargo analysts recently raised price targets on ELV, citing a potential peak in healthcare utilization growth. Mizuho expects a tough year ahead for hospitals in 2026 due to diminishing post-COVID tailwinds and legislative risks.

Elevance Health Inc. (NYSE: ELV) operates in the health benefits sector with four segments. Mizuho revised price targets across healthcare facilities and managed care sectors, noting a slowdown in healthcare utilization growth. Wells Fargo is optimistic about Medicare Advantage but cautious about Medicaid and health insurance exchanges.

Despite the investment potential of ELV, some analysts believe other AI stocks offer greater upside potential and lower downside risk. For investors interested in undervalued AI stocks benefiting from Trump-era tariffs, consider the best short-term AI stock. Check out Insider Monkey for more stock recommendations and market insights.

No promotional or marketing content included in the news summary.

Read more at Yahoo Finance: Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth